In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cephalon's Double Trouble: DoJ Probes Treanda Marketing, Clinical Trial Data

This article was originally published in The Pink Sheet Daily

Executive Summary

The inquiry comes three years after the company settled a government investigation of off-label marketing of three other drugs.
Advertisement

Related Content

No End In Sight: Pharma Companies Continue To Face Government Probes
No End In Sight: Pharma Companies Continue To Face Government Probes
In Cephalon, Teva Will Get An Expanded Innovative R&D And Branded Portfolio
Teva Will Pay $315 Million For Drug Pricing Suits
Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs
Cephalon Must Report Payments To Physicians In Settlement Of Off-Label Charges
Cephalon Must Report Payments To Physicians In Settlement Of Off-Label Charges

Topics

Advertisement
UsernamePublicRestriction

Register

PS072490

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel